Welcome to St. Boniface Clinic

St. Boniface Clinic was founded in 1950 and is conveniently located at the corner of Tache Avenue and Goulet Street in the community of St. Boniface. Our family physicians and specialists along with their dedicated staff are committed to providing you with exceptional care and attention.

To phone a physician's office direct - please click on top menu item called "Our Doctors"

To see who's NEW to the Clinic -  click here http://www.stbclinic.com/resources/your-first-visit

NEW DOCTOR

Dr Aaron MacAulay Family Physician - Starting August 2021

Please call 204-925-9545 to set up a meet and greet!

VACCINE INFORMATION: 

Eligibility Criteria for AstraZeneca:

The COVID-19 Vaccine is provided to the clinic through Manitoba Health. Supplies are limited and may not be readily available. We have been asked by the province to prioritize based on the following current guidelines as per below. 

Please speak with your health care provider if you qualify!

Are you eligible? Click here - https://www.gov.mb.ca/covid19/vaccine/eligibility-criteria.html

Resources and Forms (This includes Consent Forms & Fact Sheets for Pfizer, Moderna & AstraZeneca)

Click here - https://www.gov.mb.ca/covid19/vaccine/resources.html

Questions and Answers on everything you need to know - Click here https://www.manitobavaccine.ca/

Eligibility Criteria

As part of the piloted roll-out of the AstraZeneca/Covishield, Manitobans aged 50 to 64 years (First Nations people aged 30 to 64) with a high-risk condition will be the first group eligible to receive the AstraZeneca/Covishield COVID-19 vaccine. These individuals are at increased risk of experiencing serious illness requiring hospitalization or death related to COVID-19.

Anyone who is ALREADY eligible for the Pfizer/Moderna COVID-19 vaccine (such as health care workers) and is aged 18 to 64 is also eligible to receive AstraZeneca/ Covishield COVID-19 vaccine.

However, anyone who has already received a dose of the Pfizer or Moderna mRNA vaccines must use the same product for their second dose, and should not receive the AstraZeneca/Covishield vaccine.

People with high-risk conditions (as determined by their doctor or pharmacist) will be prioritized, with those who have a condition in Priority List 1 being offered immunization before those with a condition in Priority List 2.

Priority List 1:

• Individuals with the following chronic health conditions:
• end stage renal disease undergoing hemodialysis OR peritoneal dialysis
• cirrhosis due to any cause OR portal hypertension
• heart failure (class III/IV ), ventricular assist device OR adult congenital heart disease stage C and D
• severe COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease OR cystic fibrosis
• history of cerebral vascular accident with residual deficits
• malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
• malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
• severe obesity (BMI ≥ 40)
• receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
• solid organ or hematopoietic stem cell transplant (candidate or recipient)
• trisomy 21 (Down syndrome)
• asplenia or hyposplenism (including sickle cell disease)
• Individuals receiving home care ≥ 4 times/week OR receive 24/7 support from Community Living Disability Services.
• Pregnant individuals (18 to ≤ 64 years of age) with one of: aged ≥ 35 years, BMI ≥ 30, pre-existing diabetes, pre-existing hypertension, cardiac or pulmonary disease.

Priority List 2:

• Individuals with the following chronic health conditions:
  • Chronic cardiovascular disease including heart failure (class I/II), coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
  • chronic liver disease
  • chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson’s disease, multiple sclerosis, ALS OR dementia (including Alzheimer’s disease)
  • chronic pulmonary disease including COPD OR severe and/or uncontrolled asthma
  • chronic renal disease
  • HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
  • severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
  • type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
  • active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
  • receiving immunosuppressing therapy
• Individuals receiving homecare ≤ 3 times/week OR any level of Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
• Household contacts of individuals with Priority 1 chronic health conditions OR designated support person(s) for personal care home residents (in the authorized age category).